ProfileGDS5678 / 1440570_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 21% 22% 22% 19% 20% 21% 38% 32% 21% 22% 22% 23% 21% 22% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.5337121
GSM967853U87-EV human glioblastoma xenograft - Control 22.5134522
GSM967854U87-EV human glioblastoma xenograft - Control 32.5123522
GSM967855U87-EV human glioblastoma xenograft - Control 42.4120219
GSM967856U87-EV human glioblastoma xenograft - Control 52.438220
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5615521
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.9420238
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.7143732
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4755721
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4983522
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.5042822
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.500523
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.5046521
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.5042822